X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9198) 9198
Publication (1137) 1137
Book Chapter (63) 63
Book Review (42) 42
Conference Proceeding (16) 16
Data Set (3) 3
Dissertation (2) 2
Government Document (2) 2
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
apoptosis (5806) 5806
humans (5503) 5503
animals (4076) 4076
bcl-x protein (3676) 3676
index medicus (3188) 3188
apoptosis - drug effects (2534) 2534
mice (2455) 2455
bcl-x protein - metabolism (2348) 2348
proto-oncogene proteins c-bcl-2 - metabolism (2320) 2320
bcl-x (2241) 2241
biochemistry & molecular biology (1961) 1961
cell biology (1788) 1788
oncology (1782) 1782
cell line, tumor (1616) 1616
proto-oncogene proteins c-bcl-2 - genetics (1533) 1533
expression (1471) 1471
male (1449) 1449
proteins (1387) 1387
female (1384) 1384
bcl-2 (1319) 1319
bcl-x protein - genetics (1281) 1281
cancer (1259) 1259
apoptosis - physiology (1142) 1142
bcl-x-l (1125) 1125
death (1105) 1105
activation (1103) 1103
rats (1029) 1029
bax (1023) 1023
bcl-2-associated x protein (978) 978
signal transduction (964) 964
mitochondria (961) 961
caspases - metabolism (939) 939
cells, cultured (900) 900
cell-death (892) 892
phosphorylation (879) 879
proto-oncogene proteins - metabolism (827) 827
mitochondria - metabolism (805) 805
gene expression (793) 793
cell death (791) 791
cell line (778) 778
blotting, western (765) 765
tumor cells, cultured (730) 730
bcl-xl (727) 727
apoptosis - genetics (726) 726
antineoplastic agents - pharmacology (710) 710
in-vivo (703) 703
transfection (695) 695
cell survival (680) 680
survival (672) 672
proto-oncogene proteins c-bcl-2 - biosynthesis (655) 655
protein (646) 646
cell survival - drug effects (644) 644
bcl-2-associated x protein - metabolism (618) 618
inhibition (597) 597
down-regulation (589) 589
article (588) 588
research (585) 585
immunology (577) 577
cytochrome-c (574) 574
proto-oncogene proteins - genetics (562) 562
flow cytometry (552) 552
bcl-2 protein (549) 549
signal transduction - drug effects (509) 509
cell proliferation (497) 497
hematology (495) 495
immunohistochemistry (492) 492
caspase 3 (487) 487
programmed cell-death (486) 486
caspase (482) 482
induced apoptosis (479) 479
in-vitro (476) 476
nf-kappa-b (476) 476
up-regulation (476) 476
gene (474) 474
neurosciences (468) 468
time factors (467) 467
protein binding (466) 466
cell proliferation - drug effects (460) 460
cell cycle (459) 459
chemotherapy (458) 458
dose-response relationship, drug (458) 458
research article (458) 458
mice, inbred c57bl (457) 457
oxidative stress (447) 447
middle aged (443) 443
multidisciplinary sciences (440) 440
rna, messenger - metabolism (440) 440
cells (434) 434
analysis (432) 432
caspase 3 - metabolism (432) 432
molecular sequence data (432) 432
proto-oncogene proteins c-bcl-2 - physiology (427) 427
p53 (423) 423
cytochrome-c release (416) 416
adult (415) 415
family (401) 401
membrane proteins - metabolism (401) 401
kinases (393) 393
biology (391) 391
medicine (386) 386
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9067) 9067
Chinese (130) 130
Japanese (15) 15
French (9) 9
Polish (8) 8
Russian (8) 8
Spanish (5) 5
German (4) 4
Korean (3) 3
Hungarian (2) 2
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 2/2007, Volume 315, Issue 5813, pp. 856 - 859
A central issue in the regulation of apoptosis by the Bcl-2 family is whether its BH3-only members initiate apoptosis by directly binding to the essential... 
Research fellowships | Protein isoforms | Medical research | Myeloid cells | Antibodies | Cytochromes | Ligands | Reports | Grants | Viability | Apoptosis | RESPONSES | FAMILY-MEMBERS | X-L | MULTIDISCIPLINARY SCIENCES | BIM | HELIX | MITOCHONDRIAL-MEMBRANE | PUMA | DOMAINS | BH3-ONLY PROTEINS | CELL-DEATH | bcl-2-Associated X Protein - chemistry | Humans | BH3 Interacting Domain Death Agonist Protein - genetics | Proto-Oncogene Proteins - chemistry | Neoplasm Proteins - metabolism | bcl-2 Homologous Antagonist-Killer Protein - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Bcl-2-Like Protein 11 | Tumor Suppressor Proteins - genetics | BH3 Interacting Domain Death Agonist Protein - chemistry | Apoptosis Regulatory Proteins - genetics | bcl-Associated Death Protein - metabolism | Membrane Proteins - metabolism | BH3 Interacting Domain Death Agonist Protein - metabolism | Protein Structure, Tertiary | Proto-Oncogene Proteins - metabolism | Cell Line | Tumor Suppressor Proteins - metabolism | Membrane Proteins - genetics | Apoptosis Regulatory Proteins - chemistry | Cells, Cultured | bcl-2-Associated X Protein - metabolism | Proto-Oncogene Proteins - genetics | Apoptosis Regulatory Proteins - metabolism | Mice, Knockout | Animals | Proteins - metabolism | Membrane Proteins - chemistry | Models, Biological | Myeloid Cell Leukemia Sequence 1 Protein | Mice | Mutation | bcl-X Protein - metabolism | Research | Peptides | Analysis
Journal Article
Molecular Cell, ISSN 1097-2765, 2005, Volume 17, Issue 3, pp. 393 - 403
Apoptosis is initiated when Bcl-2 and its prosurvival relatives are engaged by proapoptotic BH3-only proteins via interaction of its BH3 domain with a groove... 
CYTOCHROME-C | COMPLEX | SURVIVAL FACTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | MITOCHONDRIA | BIM | RELEASE | PEPTIDE | CELL-DEATH | FAMILY | MEMBER | CELL BIOLOGY | Humans | Molecular Sequence Data | Proto-Oncogene Proteins - chemistry | Neoplasm Proteins - metabolism | Genetic Complementation Test | Proto-Oncogene Proteins c-bcl-2 - metabolism | Bcl-2-Like Protein 11 | Carrier Proteins - chemistry | Proto-Oncogene Proteins c-bcl-2 - chemistry | Membrane Proteins - metabolism | Neoplasm Proteins - genetics | Peptide Fragments - genetics | Cell Survival - physiology | Binding, Competitive | Protein Structure, Tertiary | Proto-Oncogene Proteins - metabolism | Recombinant Proteins - metabolism | Amino Acid Sequence | bcl-X Protein | Peptide Fragments - metabolism | Membrane Proteins - genetics | Models, Molecular | Recombinant Proteins - chemistry | Neoplasm Proteins - chemistry | Proto-Oncogene Proteins - genetics | Recombinant Proteins - genetics | Proteins - genetics | Sequence Homology, Amino Acid | Carrier Proteins - genetics | Peptide Fragments - chemistry | Animals | Apoptosis Regulatory Proteins | Carrier Proteins - metabolism | Proteins - metabolism | Membrane Proteins - chemistry | Models, Biological | Myeloid Cell Leukemia Sequence 1 Protein | Biosensing Techniques | Ligands | Mice | Apoptosis - physiology | Proteins - chemistry | In Vitro Techniques | Proto-Oncogene Proteins c-bcl-2 - genetics
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 07/2007, Volume 50, Issue 15, pp. 3457 - 3464
A new pocket detection protocol successfully identified transient pockets on the protein surfaces of BCL-X-L, IL-2, and MDM2. Because the native inhibitor... 
MOLECULAR-DYNAMICS | CHEMISTRY, MEDICINAL | LIGAND DOCKING | FLEXIBILITY | FORCE-FIELD | SIMULATIONS | BINDING-SITES | ANTAGONISTS | INHIBITOR | P53 | PREDICTION | bcl-X Protein - chemistry | Computer Simulation | Drug Design | Models, Molecular | Protein Binding | Interleukin-2 - chemistry | Ligands | Protein Conformation | Proto-Oncogene Proteins c-mdm2 - chemistry | Binding Sites
Journal Article
Cell Death and Differentiation, ISSN 1350-9047, 12/2015, Volume 22, Issue 12, pp. 2098 - 2106
Breast cancer is the second-most frequently diagnosed malignancy in US women. The triple-negative breast cancer (TNBC) subtype, which lacks expression of the... 
MCL-1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ABT-737 | CHEMORESISTANCE | MELANOMA-CELLS | BCL-2 PROTEINS | INHIBITOR | ADDICTION | ABT-199 | INDEX PREDICTS | FAMILY | CELL BIOLOGY | Apoptosis - drug effects | Humans | Myeloid Cell Leukemia Sequence 1 Protein - metabolism | bcl-2 Homologous Antagonist-Killer Protein - genetics | bcl-X Protein - genetics | bcl-2 Homologous Antagonist-Killer Protein - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Bcl-2-Like Protein 11 | RNA Interference | bcl-X Protein - antagonists & inhibitors | Triple Negative Breast Neoplasms - pathology | Apoptosis Regulatory Proteins - genetics | Female | Membrane Proteins - metabolism | bcl-2-Associated X Protein - genetics | Proto-Oncogene Proteins - metabolism | Cell Survival - drug effects | Myeloid Cell Leukemia Sequence 1 Protein - antagonists & inhibitors | Membrane Proteins - genetics | bcl-2-Associated X Protein - metabolism | Proto-Oncogene Proteins - genetics | Sulfonamides - pharmacology | Myeloid Cell Leukemia Sequence 1 Protein - genetics | Apoptosis Regulatory Proteins - metabolism | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Triple Negative Breast Neoplasms - metabolism | Cell Line, Tumor | bcl-X Protein - metabolism | Proto-Oncogene Proteins c-bcl-2 - genetics | RNA, Small Interfering - metabolism | Original Paper
Journal Article
The FEBS Journal, ISSN 1742-464X, 07/2016, Volume 283, Issue 14, pp. 2690 - 2700
B‐cell lymphoma 2 (BCL‐2) family proteins mediate mitochondrial apoptosis by regulating mitochondrial outer membrane permeabilization (MOMP), which leads to... 
pro‐apoptotic; sensitizer | direct activator | BH3‐only | derepressor | mitochondrial apoptosis | effector | mitochondrial outer membrane permeabilization | anti‐apoptotic | B‐cell lymphoma 2 | Derepressor | Anti-apoptotic | Mitochondrial outer membrane permeabilization | Pro-apoptotic; sensitizer | Mitochondrial apoptosis | Direct activator | Effector | B-cell lymphoma 2 | BH3-only | anti-apoptotic | pro-apoptotic; sensitizer | DNA-BINDING DOMAIN | MITOCHONDRIAL OUTER-MEMBRANE | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PROMOTE APOPTOSIS | DIRECT ACTIVATION | sensitizer | CELL-DEATH | BAX ACTIVATION | CHANGES CONFORMATION | pro-apoptotic | PROLYL ISOMERASE PIN1 | PEPTIDE COMPLEX | Signal Transduction | Tumor Suppressor Protein p53 - antagonists & inhibitors | Humans | Protein Multimerization | Tumor Suppressor Protein p53 - metabolism | bcl-2-Associated X Protein - metabolism | Models, Molecular | Permeability | Mitochondrial Membranes - metabolism | bcl-X Protein - chemistry | Proto-Oncogene Proteins c-bcl-2 - metabolism | Animals | Models, Biological | Protein Conformation | Proto-Oncogene Proteins c-bcl-2 - chemistry | Protein Interaction Domains and Motifs | Tumor Suppressor Protein p53 - chemistry | Apoptosis - physiology | bcl-X Protein - metabolism | Tumor proteins | Protein-protein interactions | Protein binding | Apoptosis | Proteins | Lymphomas
Journal Article
Nature Communications, ISSN 2041-1723, 07/2017, Volume 8, Issue 1, p. 16078
BCL-2 family proteins are central regulators of mitochondrial apoptosis and validated anticancer targets. Using small cell lung cancer (SCLC) as a model, we... 
CELL LUNG-CANCER | SELECTIVE-INHIBITION | BAK ACTIVATION | POTENT | MULTIDISCIPLINARY SCIENCES | BIM | TRANSCRIPTION | DEATH | CDK INHIBITOR | ABT-263 | BH3 DOMAIN | Lung Neoplasms - drug therapy | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Myeloid Cell Leukemia Sequence 1 Protein - metabolism | Drug Resistance, Neoplasm | Molecular Targeted Therapy | Apoptosis Regulatory Proteins - drug effects | Myeloid Cell Leukemia Sequence 1 Protein - drug effects | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - metabolism | bcl-X Protein - drug effects | Proto-Oncogene Proteins c-bcl-2 - metabolism | bcl-X Protein - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Myeloid Cell Leukemia Sequence 1 Protein - antagonists & inhibitors | Aniline Compounds - pharmacology | Cyclin-Dependent Kinase 9 - antagonists & inhibitors | Sulfonamides - pharmacology | Apoptosis Regulatory Proteins - metabolism | Drug Synergism | Pyridinium Compounds - pharmacology | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | High-Throughput Screening Assays | Apoptosis Regulatory Proteins - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - drug effects | Cell Line, Tumor | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | bcl-X Protein - metabolism | Doxorubicin - pharmacology | Regulators | Bax protein | Bcl-2 protein | Small cell lung carcinoma | Lung cancer | High-throughput screening | Doxorubicin | BAK protein | Mcl-1 protein | Proteins | Mitochondria | Inhibitors | Bcl-x protein | Anthracycline | Addiction | Cell death | Sequestering | Cancer | Apoptosis
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 01/2011, Volume 286, Issue 1, pp. 491 - 501
Bcl-2 family proteins regulate a critical step in apoptosis referred to as mitochondrial outer membrane permeabilization (MOMP). Members of a subgroup of the... 
MITOCHONDRIAL-MEMBRANE PERMEABILIZATION | ANTAGONIST ABT-737 | MCL-1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | MIMETIC ABT-737 | APOPTOTIC PROTEIN BAK | SENSITIVITY | OLIGOMERIZATION | BCL-2 FAMILY-MEMBERS | BH3-ONLY PROTEINS | CELL-DEATH | bcl-2-Associated X Protein - chemistry | Humans | Protein Multimerization | Cell Membrane Permeability | Molecular Sequence Data | Proto-Oncogene Proteins - chemistry | bcl-2 Homologous Antagonist-Killer Protein - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Bcl-2-Like Protein 11 | BH3 Interacting Domain Death Agonist Protein - chemistry | HEK293 Cells | Protein Structure, Quaternary | Cell Membrane - metabolism | Membrane Proteins - metabolism | BH3 Interacting Domain Death Agonist Protein - metabolism | Protein Structure, Tertiary | Proto-Oncogene Proteins - metabolism | Amino Acid Sequence | Peptide Fragments - metabolism | Cytochromes c - secretion | Apoptosis Regulatory Proteins - chemistry | bcl-2-Associated X Protein - metabolism | Apoptosis Regulatory Proteins - metabolism | Animals | Membrane Proteins - chemistry | Liposomes - metabolism | Mice | Adaptor Proteins, Signal Transducing - metabolism | bcl-X Protein - metabolism | bcl-2 Homologous Antagonist-Killer Protein - chemistry | Apoptosis | Cytochrome c | BH3 Peptides | Mitochondria | Cell Death | Liposomes | Cell Biology | Bcl-2 Family Proteins
Journal Article
Molecular Cell, ISSN 1097-2765, 11/2011, Volume 44, Issue 4, pp. 517 - 531
Journal Article
Oncogene, ISSN 0950-9232, 09/2011, Volume 30, Issue 37, pp. 3918 - 3929
The BH3 mimetic ABT737 induces autophagy by competitively disrupting the inhibitory interaction between the BH3 domain of Beclin 1 and the anti-apoptotic... 
autophagy | ABT737 | Bcl-2 family protein | Beclin 1 | CELLS | COMPLEX | BIOCHEMISTRY & MOLECULAR BIOLOGY | IKK | INDUCTION | CELL BIOLOGY | ONCOLOGY | GENETICS & HEREDITY | BCL-2 FAMILY | BH3-ONLY PROTEINS | Phosphorylation | Nitriles - pharmacology | Ribosomal Protein S6 Kinases - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Autophagy - drug effects | Biphenyl Compounds - pharmacology | I-kappa B Kinase - metabolism | Nitrophenols - pharmacology | Phosphotransferases (Phosphate Group Acceptor) - metabolism | Benzopyrans - pharmacology | Oncogene Protein v-akt - metabolism | Proto-Oncogene Proteins c-mdm2 - metabolism | Beclin-1 | Tumor Suppressor Protein p53 - metabolism | Glycogen Synthase Kinase 3 - metabolism | Sulfonamides - pharmacology | Membrane Proteins - agonists | Piperazines - pharmacology | Signal Transduction - drug effects | Apoptosis Regulatory Proteins - agonists | Cell Line, Tumor | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Sirtuins - metabolism | Acetyl-CoA Carboxylase - metabolism | Autophagy (Cytology) | Cellular proteins | Care and treatment | Physiological aspects | Genetic aspects | Cellular signal transduction | Research | Cancer | Proteins | Signal transduction | Biomimetics | Cellular biology | Gene expression | Sirtuins | TOR protein | MDM2 protein | Bcl-2 protein | Glycogen synthase kinase 3 | AKT protein | Dephosphorylation | IKK protein | p53 protein | Allosteric properties | NF- Kappa B protein | Bcl-x protein | I Kappa B kinase | Lipid kinase | Phagocytosis | Ubiquitin-protein ligase
Journal Article